BriaCell Therapeutics Corp. (NASDAQ:BCTX – Get Free Report) was the recipient of a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 464,400 shares, a decline of 18.4% from the July 15th total of 569,400 shares. Currently, 3.0% of the company’s shares are sold short. Based on an average daily volume of 377,200 shares, the days-to-cover ratio is currently 1.2 days.
Analyst Upgrades and Downgrades
Separately, HC Wainwright restated a “buy” rating and issued a $18.00 price target on shares of BriaCell Therapeutics in a report on Tuesday, June 4th.
Check Out Our Latest Stock Report on BCTX
Hedge Funds Weigh In On BriaCell Therapeutics
BriaCell Therapeutics Price Performance
Shares of NASDAQ:BCTX remained flat at $0.56 during trading on Friday. 124,166 shares of the stock were exchanged, compared to its average volume of 204,671. The business’s 50-day simple moving average is $0.93 and its two-hundred day simple moving average is $2.04. BriaCell Therapeutics has a fifty-two week low of $0.52 and a fifty-two week high of $7.59. The company has a market capitalization of $10.23 million, a price-to-earnings ratio of -0.45 and a beta of 1.29.
BriaCell Therapeutics (NASDAQ:BCTX – Get Free Report) last released its quarterly earnings data on Friday, June 14th. The company reported $0.11 EPS for the quarter, topping the consensus estimate of ($0.55) by $0.66. On average, sell-side analysts expect that BriaCell Therapeutics will post -1.39 EPS for the current fiscal year.
BriaCell Therapeutics Company Profile
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.
See Also
- Five stocks we like better than BriaCell Therapeutics
- What is a Stock Market Index and How Do You Use Them?
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Why Are Stock Sectors Important to Successful Investing?
- MarketBeat Week in Review – 8/12 – 8/16
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.